Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Three scientists are honoured for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

( NewsNation) — Losing muscle mass isn’t the only potential side effect of taking weight loss medications such as Ozempic: ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

Kids as young as six years old could soon be allowed access to a weight loss drug, similar to Ozempic, to help reduce obesity ...

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...